Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2

Abstract Background The ongoing COVID-19 pandemic has resulted in 185 million recorded cases and over 4 million deaths worldwide. Several COVID-19 vaccines have been approved for emergency use in humans and are being used in many countries. However, all the approved vaccines are administered by intr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Huibi Cao, Juntao Mai, Zhichang Zhou, Zhijie Li, Rongqi Duan, Jacqueline Watt, Ziyan Chen, Ranmal Avinash Bandara, Ming Li, Sang Kyun Ahn, Betty Poon, Natasha Christie-Holmes, Scott D. Gray-Owen, Arinjay Banerjee, Karen Mossman, Rob Kozak, Samira Mubareka, James M. Rini, Jim Hu, Jun Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-12-01
coleção:	Cell & Bioscience
Assuntos:	COVID-19 HD-Ad Nasal delivery SARS-CoV2 Vaccine
Acesso em linha:	https://doi.org/10.1186/s13578-021-00723-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!